ZDHHC3 downregulation is related to an m6A increase when ALKH5B is inhibited, which suppresses PD-L1 expression, making tumor cells a potential target for PD-1 and PD-L1 inhibitors [69]. This evidence concerns the gene CD274 and neoplasm.